UBS Group
INGN icon

UBS Group’s Inogen INGN Stock Holding History

UBS Group’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-94,000
Closed -$8.96M – 7995
2019
Q1 		$8.96M Buy
+94,000
New +$11.7M ﹤0.01% 1762

Other funds holding INGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's INGN Position: Q2 2026 in Review

UBS Group increased its Inogen (INGN) stake by 63% in Q2 2026, buying an estimated $775K and bringing the position to 301,596 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #5133.

UBS Group first reported a position in INGN in Q4 2014 and has held it in 47 quarters since. The position peaked at $8.96M in Q4 2018. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • UBS Group held 301,596 shares of Inogen worth $1.95M as of Q2 2026.
  • UBS Group bought 117,087 Inogen shares in Q2 2026, an estimated $775K.
  • Inogen made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5133 holding.
  • UBS Group first reported a position in Inogen in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Inogen position peaked at $8.96M in Q4 2018.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.